Apr. 11, 2019
AMR INDUSTRY REPORT AND CASE STUDY BIOVERSYS
The AMR has launched its first report which shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR).
The AMR Industry Alliance is one of the largest private sector coalitions set up to
provide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces.
Please have a look at the Case Study for BioVersysCase Study BioVersys